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The virome contains the most abundant and fastest mutating genetic elements on Earth. The
mammalian virome is constituted of viruses that infect host cells, virus-derived elements in our
chromosomes, and viruses that infect the broad array of other types of organisms that inhabit
us. Virome interactions with the host cannot be encompassed by a monotheistic view of viruses
as pathogens. Instead, the genetic and transcriptional identity of mammals is defined in part by
our coevolved virome, a concept with profound implications for understanding health and disease.Introduction
This Review describes the importance of the virome in mamma-
lian biology and emerging concepts of virome-host interactions
and their relationship to host genetics (Figure 1). The virome is
one part of the microbiome, which constitutes all of the organ-
isms that inhabit us, including bacterial and archaeal organisms
as well as the mycobiome and other members of the meiofauna
such as protists andmetazoans. Studies of the virome are in their
infancy because it has only recently become possible to ‘‘see’’
the virome in large sequence data sets using bioinformatic tools
that can detect relationships between viruses despite extreme
nucleotide sequence diversity (Angly et al., 2005; De Vlaminck
et al., 2013; Handley et al., 2012; Lysholm et al., 2012;
Minot et al., 2012; Mokili et al., 2012; Reyes et al., 2010, 2012;
Willner et al., 2009). Studies of the virome have lagged behind
analyses of the bacterial microbiome, which is detectable
through inexpensive sequencing of conserved bacterial ribo-
somal genes, a luxury not available to virome investigators.
Nevertheless, it appears that, as for bacteria, there are chronic
viruses that may be considered commensals, the penetrance
of overt disease in virus-infected persons is low in some cases,
and viruses alter disease susceptibility via significant physiologic
effects on the host independent of their role as pathogens. Given
these advances, it is timely to consider the role of the virome in
phenotypic and disease variations among individuals—termed
here the genotype/phenotype relationship.
The mammalian virome (Virgin et al., 2009) includes viruses
that infect eukaryotic cells (eukaryotic virome); bacteriophages
that infect bacteria (bacterial virome); viruses that infect archaea
(archaeal virome); and virus-derived genetic elements in host
chromosomes that can change host-gene expression, express
proteins, or even generate infectious virus (prophages, endoge-
nous retroviruses, endogenous viral elements) (Figure 1). Of the
different types of viruses found in mammals, the least is known
about the archaeal virome, although these viruses have some in-
teractions with their host cells similar to those observed between
bacteriophages and bacteria (Gill andBrinkman, 2011; Prangish-
vili, 2013). It is useful to consider all of these viruses and virus-142 Cell 157, March 27, 2014 ª2014 Elsevier Inc.related sequences as members of the virome because they
can generate infectious viruses under at least some circum-
stances and encode proteins that participate in viral replication
or that have evolved from such proteins. One might consider
prions as part of the virome, but herein, we will consider ele-
ments with nucleic acid genomes.
Eukaryotic viruses and bacterial viruses differ in many regards
but similarly utilize both ‘‘lytic’’ life cycles in which the host cell is
destroyed during viral replication and ‘‘latent’’ life cycles in which
the virus stably resides within a living cell. Latency is the survival
of the viral genome either integrated into the host chromosome
(e.g., prophages) or as an episome (e.g., herpesviruses) until
the need arises to reactivate and become infectious. This variety
of life styles allows the virome to survive, evade defenses, diver-
sify, and evolve amazingly complex, sometimes mutualistic,
symbiotic relationships with the host. Importantly, these relation-
ships are often ‘‘trans-kingdom’’ in nature, defined as involving
virome interactions with organisms within the microbiome from
different kingdoms of life (for example virome interactions with
bacteria).
Members of the virome fill a variety of ecological niches in their
hosts. Members of the eukaryotic virome that chronically infect
mammals, including humans, have significant effects on host
physiology outside of the simple paradigm of invasion and tissue
destruction that has been the focus of much work on viruses
(Foxman and Iwasaki, 2011; Stelekati and Wherry, 2012; Virgin
et al., 2009). This suggests that, as the virome is further charac-
terized and annotated, new pathogens, symbiotes, mutualistic
symbiotes, and virus-related genetic elements in host chromo-
somes will be identified.
In mammals, the virome inhabits (in addition to the chromo-
somes themselves) all mucosal surfaces. After clearance of
acute viral infection, viruses can also persist in systemic niches
in neurons, hematopoietic cells, stem cells, vascular endothelial
cells, and likely many additional cell types. For example, after re-
covery from acute infection, herpesviruses canmaintain life-long
latent infection in neurons, hematopoietic progenitors, and long-
lived lymphocytes. This is a significant difference between the
Figure 1. Components of the Virome and Their Relationship to the Genotype/Phenotype Relationship
The mammalian virome changes rapidly over time both through exchange of viruses with other organisms and through evolution of the individual viruses that
constitute the virome. The major components of the virome are the eukaryotic virome, endogenous viral elements, and the prokaryotic virome, which includes
viruses of both bacteria and archaea. Members of the virome influence the phenotype of the host in a combinatorial manner by interacting with other members of
the microbiome (such as other members of the virome itself, the bacterial microbiome, the mycobiome, or the meiofauna) and by interacting with individual
variations in host genetics. Together these interactions may influence a range of phenotypes, shown on the right, important for health and disease.virome and the bacterial microbiome, members of which are not
known to persist systemically. The systemic nature of the virome
permits it to influence the host in ways that other members of the
microbiome do not.
Membership in the Virome
The Earth’s DNA and RNA virome is enormous with an estimated
1031 members when sources such as the ocean are included.
This extrapolated estimate is uncertain but indicates the scale
and potential complexity of the virome. One estimate is that we
have now explored about 1% of the virome at the sequence level
(Mokili et al., 2012), but the biological analysis of the virome is far
behind even that low estimate. The size of the mammalian
virome is not known. Although our own cells are outnumbered
about 10-fold by our bacterial microbiome, the number of viruses
may be 10-fold higher still (Mokili et al., 2012). Human feces
alone contain ca. 108–109 viruses per gram (Mokili et al., 2012;
Reyes et al., 2012). Additionally, the mammalian virome is
continuously ‘‘updated’’ through rapid evolution of viruses and
through exposure to viruses in the environment or in other mam-
mals (Figure 1).
The eukaryotic virome has likely been underestimated
because methods for sequencing metagenomes have, surpris-
ingly, often ignored RNA viruses. Some of themost important hu-
man and veterinary pathogens are RNA viruses (e.g., influenza,
rotavirus, arboviruses, hepatitis C virus), and so the identification
of the RNA virome is an important priority. Evidence that the RNA
virome in mammals is much more extensive than currently
recognized comes from deep sequencing of samples from hu-
mans, pigs, bats, sea lions, wild rodents, and macaques with
AIDS (Finkbeiner et al., 2008; Handley et al., 2012; Li et al.,2011; Phan et al., 2011; Shan et al., 2011; Smith and Wang,
2013) (Figure 1). Multiple RNA viruses that are human pathogens,
including SARS, Nipah virus, Hendra virus, and Ebola, have
arisen in bats alone (Smith andWang, 2013). Another contributor
to underestimating the eukaryotic virome is likely the use of harsh
isolation procedures that may result in a failure to detect giant
viruses in mammalian virome samples (Colson et al., 2013;
Popgeorgiev et al., 2013).
The great majority of sequences present in purified ‘‘virus’’
samples defy annotation because they are not related to
currently identified viruses at all or have extensively diversified
from known viruses through rapid evolution. Importantly, our
definition of virus as yet relies on similarities to known viruses
at the protein-sequence level because of the enormous vari-
ability of these organisms at the nucleic acid level and the inad-
equacy of reference databases. Thus, the virome may include
novel virus types that have not yet been identified in addition
to those with a detectable similarity to known viruses.
As the virome is better defined, viral signatures in our chromo-
somes will increasingly be possible to identify (Figure 1). There
are now ‘‘fossil’’ remains of many known DNA and RNA virus
types in our genomes (Feschotte and Gilbert, 2012; Holmes,
2011; Patel et al., 2011), reflecting the role of the eukaryotic vi-
rome in gene transfer and evolution. Importantly, these endoge-
nous viral elements may regulate gene expression, participate in
mutagenic events, and encode mRNAs for proteins with impor-
tant functions (Feschotte and Gilbert, 2012; Holmes, 2011; Patel
et al., 2011). The best described of these ‘‘domesticated’’ viral
genes are the syncitins, which are derivative of endogenous
retroviral genes and now participate in placentation. Further
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the structure and evolution of our own genomes by identifying
the potential origins and functions of a subset of mammalian
genes and proteins.
Invaders from the Virome as Traditional Pathogens
The virome has an important impact on the health ofmammals as
the source for traditional viral pathogens. From the recognition of
viral diseases such as polio or yellow fever in ancient times to the
discovery that filterable agents cause disease to the linkage of
individual viruses to specific diseases such as rabies or influ-
enza, this dominant paradigm has had an enormous impact on
human health. Most of these studies relied on detection of
viruses through the capacity to grow them in cultured cells or
animals. However, culture-dependent approaches have failed
to reveal a causative agent for many apparently ‘‘infectious’’ dis-
eases or to definitively link individual viruses to autoimmune dis-
eases. Nevertheless, new pathogenic viruses continue to be
discovered at a high rate. Between 1980 and 2005, an estimated
87 pathogens were discovered, about 67% of which were viral
(Rosenberg et al., 2013; Woolhouse et al., 2008). Discovery of
new pathogenic viruses is likely to continue, and even increase
for a period of time, as next-generation sequencing of RNA
and DNA libraries plummets in cost, bioinformatic tools improve
and become generally available, and viral databases are
expanded and more accurately curated. Thereafter, new viral
pathogens will likely continue to appear through mutation,
recombination, zoonotic transmission, and engineering of vi-
ruses for therapeutic or military purposes. The role of the virome
as a source of pathogens that cause infectious diseases will
continue for the foreseeable future.
The Virome Is More Than a Source of Pathogens
The virome is far more than a source of deadly threats to human
and animal welfare. In fact, asymptomatic hosts carry multiple
viruses, and interactions between the virome and the host do
not always involve the death of virus-infected cells. This concept
has led to the emerging paradigm that the virome can influence
the host in profound ways independent of classical viral disease.
As systemic viruses are frequently inherited from parents very
early in life, either by vertical or horizontal transmission soon after
birth, the viromemay be properly seen as a significant part of our
individual genetic identity, whether or not the virus is integrated
into our chromosomes (Virgin et al., 2009). Data supporting these
emerging concepts is only now appearing, making this an
exciting area of virology and immunology. Evolution of our view
of viruses to encompass symbiosis, sometimes mutualistic sym-
biosis, as well as pathogenesis and virulence has the potential to
significantly impact our understanding of our own genetics,
health, and disease.
The immune system is not a static entity—it is in a constant
state of activation in between episodic infectious or oncogenic
threats. The immune system is in dynamic equilibrium with all
components of the microbiome, including the virome, in the
asymptomatic state. This ‘‘normal’’ state may vary from person
to person, or change over time, and is termed herein the host im-
munophenotype. Many of the processes in the immune system
that are activated in asymptomatic individuals are regulated by
cytokines emanating from immune cells that recognize antigens144 Cell 157, March 27, 2014 ª2014 Elsevier Inc.or pathogen-associated molecular patterns (PAMPS) including
those from viruses. These cytokines act at a distance on
bystander cells not actively involved in threat recognition. As
many ‘‘nonimmune’’ cells have receptors for these cytokines,
there is the potential for ongoing inflammatory processes to
have broad effects on physiology. For example, interferon-g is
a key cytokine regulating many aspects of both innate and
adaptive immunity through interaction with its receptor. The
interferon-g receptor is located on all cells in the body with the
exception of erythrocytes, and therefore this cytokine can have
both immune and nonimmune effects (Farrar and Schreiber,
1993).
It is likely that many components of the mucosal microbiome,
such as bacteria and fungi, stimulate low-level immune re-
sponses in asymptomatic individuals. Recent work shows that
the virome can continuously stimulate the immune system in a
similar way. We are constantly reinfected by common low-viru-
lence viruses that repeatedly stimulate mucosal host responses,
with potential consequences for host resistance to other infec-
tions and susceptibility to diseases such as asthma and type 1
diabetes (Foxman and Iwasaki, 2011). Increasingly, these
‘‘acute’’ viruses are recognized to persistently infect a proportion
of our population, a phenomenon familiar to bacteriologists who
understand that pathogens such as Staphylococcus aureus and
pneumococcus are carried in the nasopharynx of healthy individ-
uals (Bosch et al., 2013; Foxman and Iwasaki, 2011). This chronic
carrier state for viruses has likely been underestimated due to the
lack of inexpensive and high-quality tools to detect and quantify
extremely diverse members of the virome. As the virome is
further defined in more healthy people, the proportion and num-
ber of viruses that regulate the immunophenotype by both
causing acute disease and persisting in some asymptomatic in-
dividuals will likely increase.
In addition to these mucosal components of the virome, the
immune system is continuously stimulated by chronic systemic
viruses. This aspect of host-microbiome interactions appears
specific to the virome. It is estimated that an individual healthy
human harbors >10 permanent chronic systemic viral infections,
but this numbermay be far higher because the virome has not yet
been fully defined (Virgin et al., 2009). These include herpesvi-
ruses, polyomaviruses, anelloviruses, adenoviruses, papilloma-
viruses, and, for many of us, additional viruses such as hepatitis
B virus, hepatitis C virus, and HIV. These infections drive contin-
uous activation of the immune system in response to PAMPs and
antigens generated as they reactivate from latency or continu-
ously replicate. The role of such active immune surveillance in
control of these systemic additions to our individual genetic
identities is clear from the fact that these viruses often cause dis-
ease when immunosurveillance fails as, for example, in the
setting of acquired immunodeficiency.
It is easy to understand how interindividual variations in this
asymptomatic systemic virome may contribute to phenotypic
variations between hosts, as discussed in more detail below.
This applies also to experimental animals housed in different en-
vironments, potentially contributing to variation in experiments in
animal models (Basic et al., 2014; Cadwell et al., 2010; Young
et al., 2012). In this vision of our metagenome, variations in
the systemic virome may contribute to phenotypic variation by
Figure 2. One Possible Mechanism for the Influence of the Virome
on Host Phenotype
Because the virome differs between individuals, and becausemultiple sensors
of viral infection can induce overlapping but distinct transcriptional effects, the
virome of asymptomatic individuals may play an important role in regulating
the transcriptional state of healthy people. This transcriptional state is referred
to in the text as the immunophenotype of the host. Individuals may then
respond to triggers of disease in different ways in a manner dependent on the
nature of their individual viromes and genetic constitution.regulating immunophenotype rather than by acting as pathogens
(Figures 1 and 2). It is interesting in this regard that idiopathic
systemic inflammation has been linked to many of the most
severe public health threats of western society, including dia-
betes, cardiovascular disease, and the metabolic syndrome.
The actual drivers of this inflammation are not yet fully defined,
but the systemic and mucosal virome is certainly a candidate.
Even aging may be influenced by the continuous stimulation of
the immune system by the virome. This is exemplified by the
role of chronic infection with cytomegalovirus, and perhaps other
herpesviruses, in immune senescence of T cell responses,
perhaps leading to decreased resistance to infection and cancer
in the elderly (Fu¨lo¨p et al., 2013).
TheBacterial Virome Interactswith theMammalianHost
The enteric bacterial virome is highly variable between individ-
uals, incredibly diverse, and responsive to environmental stimuli(Minot et al., 2012; Reyes et al., 2010). Bacteriophages regulate
the bacterial microbiome via gene transfer, killing competing
bacteria to allow invasion of prophage-containing bacteria to
fill a partly emptied niche, or by encoding toxins that alter the
host intestine to foster bacterial pathogenesis (Duerkop and
Hooper, 2013). Given the importance of the bacterial micro-
biome to our physiology, these effects of the bacterial virome
may have a profound impact on health and disease.
In addition to the accepted role of the bacterial virome in regu-
lating the bacterial microbiome, there are tantalizing hints that
this part of the virome may also directly interact with the immune
system (Figure 2). Free bacteriophage particles in the intestine
can contact epithelial cells and, via breaks in the intestinal
mucosa or dendritic cell transport, may access the lamina prop-
ria and spread systemically (De Vlaminck et al., 2013; Duerkop
and Hooper, 2013). Bacteriophages are immunogenic enough
to generate antibodies in human infants (Uhr et al., 1962). Addi-
tionally, endotoxin-free bacteriophage particles are reported to
stimulate production of interleukin-1b (IL-1b) and tumor necrosis
factor alpha (TNF-a) by macrophages (Eriksson et al., 2009).
CpG motifs in bacteriophage genomes, which stimulate inter-
feron production, may protect against vaccinia virus infection
(Mori et al., 1996). Bacteriophage proteins have been reported
to enhance DNA vaccine potency (Cuesta et al., 2006). An inter-
esting concept is that tailed DNA bacteriophages, about 25% of
which bindmucins via immunoglobulin-like domains, may confer
‘‘innate’’ resistance to bacterial infection by populating themucin
layer over mucosal surfaces awaiting unsuspecting phage-sus-
ceptible bacteria (Barr et al., 2013). Bacteriophages can also
benefit a multicellular organism through infection of a mutualistic
bacterial endosymbiont. For example, aphids are protected
against the injection of a parasitic wasp larva by bacteria that
produce a toxin that kills the implanted larvae. The toxin is sup-
plied by a bacteriophage that infects the bacterial endosymbiont
(Roossinck, 2011). Together these data indicate that the bacte-
rial, and likely archaeal, viromes are an underexplored part of
our individual genetic identities that may confer resistance or
susceptibility to disease in ways independent of their day job
as shepherds of the bacterial or archaeal microbiome.
The Eukaryotic Virome—New Roles in Host-Virus
Interactions
An emerging concept is that the virome may contain mutualistic
symbiotes with some effects that benefit the host and others that
may be harmful (Figure 1). In an example of mutualistic symbio-
sis, chronic infection of mice with a g-herpesvirus increases
resistance to Listeria monocytogenes and Yersinia pestis (Barton
et al., 2007) and activates natural killer (NK) cells, resulting in
increased resistance to tumor grafts (White et al., 2010). We
should not be surprised by such emerging observations as
they simply bring mammals into a world of viral mutualistic sym-
biosis that has been observed in many other organisms. For
instance, cucumber mosaic virus is a common plant pathogen
that decreases crop biomass; however, plants infected by this
virus and others are resistant to drought (Bao and Roossinck,
2013). Curvularia thermal tolerance virus confers heat tolerance
to plants via infection of a fungus that lives in the plant (Bao
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conceptualizing how the mammalian virome may function in dis-
ease and normal physiology, this mutualistic symbiosis appears
related to viral infection changing the expression of genes in the
fungus such that it can confer heat tolerance to the plant (Bao
and Roossinck, 2013; Ma´rquez et al., 2007; Morsy et al., 2010).
In another remarkable process in which gene expression
changes during viral mutualistic symbiosis, Dysaphis plantage-
nea densovirus infection of aphid nymphs promotes differentia-
tion to awinged form that promotes spread of both the aphid and
virus (Roossinck, 2011).
Virome Interactions with Other Kingdoms of Life
The virome can influence the host through interactions with other
types of organisms within the microbiome (trans-kingdom inter-
actions herein) (Figure 1). Perhaps because of the complexity of
these interactions and the difficulty in defining mechanisms for
them, the current approach to understanding the virome and
other components of the microbiome is in some ways similar
to the earth-centric view of the universe before the Copernican
revolution. We tend to view the interactions between compo-
nents of the microbiome as revolving around us as the center
of our metagenomic universe. The real truth is that complex in-
teractions between kingdoms are formative for physiology, and
that coinfections are the rule, not the exception. This complexity
is very poorly understood.
The difficulty of analyzing trans-kingdom interactions involving
the virome is increased by the fact that our scientific culture
tends to limit interchange between groups with expertise in the
different components of our metagenome. Many outstanding
studies of the bacterial microbiome interpolate that effects are
due to alterations in bacteria, without measuring or acknowl-
edging the archaea, the virome, or the mycobiome and other
components of the meiofauna (Norman et al., 2014). Virologists
are as narrow in their weltanschauung, most frequently attrib-
uting viral virulence to viral genes alonewhen there are numerous
examples of virus-induced disease being mediated by bacteria.
Furthermore, neither bacteriologists nor virologists properly
include the mycobiome or the meiofauna in their considerations
(Findley et al., 2013; Iliev et al., 2012; Norman et al., 2014). A
nonsectarian approach recognizing that diseases and physio-
logic processes are reasonably viewed as ecological problems
of interactions between groups of organisms, including the
virome, and their environment may provide important tools for
understanding mammalian biology.
Perhaps the best studies of trans-kingdom interactions have
been of infections of the respiratory tract where there is exten-
sive evidence for both bacteria-bacteria and virus-bacteria inter-
actions (Bosch et al., 2013; Foxman and Iwasaki, 2011). A classic
example of a trans-kingdom effect of the virome is the increase
in pneumococcal and staphylococcal pneumonia seen during
influenza pandemics. Trans-kingdom interactions in which
viruses worsen bacterial infection in the respiratory system are
increasingly well studied (Bosch et al., 2013; Foxman and Iwa-
saki, 2011; Lysholm et al., 2012; Willner et al., 2009). There is
growing evidence that the nasopharynx is chronically infected
with viruses, often multiple viruses, in normal individuals. It will
be interesting to consider how this respiratory virome (Lysholm
et al., 2012; Willner et al., 2009) relates to lung transplant rejec-146 Cell 157, March 27, 2014 ª2014 Elsevier Inc.tion and inflammatory diseases such as asthma, chronic
obstructive pulmonary disease, and chronic bronchitis.
In a fascinating example of trans-kingdom interactions in-
volving the virome, recent work has shown that the bacterial
microbiome regulates the antiviral T cell and macrophage re-
sponses to influenza and lymphocytic choriomeningitis virus
(LCMV) (Abt et al., 2012; Ichinohe et al., 2011). Furthermore, bac-
terial products contribute to the infectivity of retroviruses and en-
teroviruses (Kane et al., 2011; Kuss et al., 2011). Other examples
of critically important trans-kingdom interactions involving the
virome include the inhibitory effects of Schistosoma mansoni
infection on T cell responses to vaccinia and hepatitis C virus
(Actor et al., 1993; Kamal et al., 2001) and the synergistic effects
of malaria and HIV infections in enhancing the spread of both in-
fections (Abu-Raddad et al., 2006). A novel recent example of
trans-kingdom interactions involving the virome comes from
the observation that RNA viruses infecting organisms such as
the pathogens Leishmania and Trichomonas increase the inflam-
matory response in humans by triggering TLR3 signaling (Fichor-
ova et al., 2012; Ives et al., 2011).
‘‘Virus-plus-Host-Gene’’ Effects of the Virome
The virome, and trans-kingdom interactions involving the virome,
can interactwith genetic variation in the host to determine pheno-
types (Figure 1). In the simplest case, severe virus-induced dis-
ease occurswhen specific antiviral host pathways are genetically
disrupted, demonstrating that human genetic diversity in re-
sponses to virus infection, and by extension the virome, may
be responsible for significant phenotypic variation (Sancho-
Shimizu et al., 2011). Similarly, both innate immune sensors
and the adaptive immune system are important for control of
endogenous retroviruses (Young et al., 2012; Yu et al., 2012).
Specific interactions between a viral strain and host allelic vari-
ation can lead to phenotypes not observedwith either the virus or
the host variation alone. In this way, virus-plus-host-gene com-
binations can contribute to host fitness or disease risk in a
manner that could contribute to understanding the as-yet-unex-
plained genetic ‘‘dark matter’’ that prevents host genotype from
fully explaining disease risk (Figure 1) (Virgin and Todd, 2011).
For example, persistent murine norovirus infection interacts
with low expression of Atg16L1, an autophagy gene with allelic
variants that predispose to Crohn’s disease, to induce disease
not observed with either virus infection or Atg16L1 mutation
alone (Cadwell et al., 2010). Remarkably this virus-plus-host-
gene-triggered inflammatory response is mitigated by antibiotic
treatment, indicating that trans-kingdom interactions with bacte-
ria play a role in virus-plus-host-gene-induced pathology (Cad-
well et al., 2010). The virus-plus-host-gene concept, including
the role of bacteria in virus-induced pathology in the setting of
a specific host mutation, has been confirmed in an independent
study of norovirus infection of mice mutant for IL-10 (Basic et al.,
2014). This relationship is reciprocal as variations in the host
genome can define the phenotypes of viral mutants, including
by host immunodeficiency specifically complementing attenua-
tion of viruses with mutations in immune evasion genes (Leib
et al., 1999, 2000).
Components of the virome can also interact in physiologically
important ways with each other. HIV infection leads to changes
in expression of endogenous retroviral elements (Contreras-
Galindo et al., 2013; Li et al., 2013). Further, expression of
Epstein-Barr virus latency genes can increase the expression
of a human endogenous retrovirus-related superantigen that
prunes the T cell repertoire (Sutkowski et al., 2001, 2004). These
data indicate that interactions that involve the virome have, in
combination with variations in our host genomes, a potentially
significant role in generating phenotypes that cannot be pre-
dicted when considering host genes or viruses independently
(Figure 1).
The existence of these trans-kingdom interactions with the
virome means that understanding some aspects of mammalian
biology, including treatment or prevention of disease, will likely
require defining the virome and its role in mammalian physiology
in detail. A major approach to developing therapeutics is based
on the concept that diseases are single entities that can effec-
tively be targeted by identifying mechanisms within the mamma-
lian host. This reductionist view of complex disease is highly
valuable but does not account for the role of the metagenome
and its components including the virome (Virgin and Todd,
2011). We are all too often surprised when a therapeutic or vac-
cine ‘‘fails’’ without obvious cause. There are certainly many
causes for this (e.g., off-target effects of drugs in human cells),
but one might speculate that therapeutic development is overly
focused on a single part of the metagenome driven by a
human-centric view of what is really a more complex metage-
netic organism. In this view, the virome, perhaps through control
of the immunophenotype, may be a primary determinant of
human variation in drug and vaccine responses either by its
direct effects on transcription of the host (see below), through
trans-kingdom interactions, or through virus-plus-host-gene-
driven phenotypes.
The Virome as a Determinant of Our ‘‘Normal’’
Transcriptional State
Is there an underlying principle that might explain the effects of
the virome on the host that are outside of the traditional role of
viruses as pathogens? One possible unifying concept is that
the virome acts by altering the transcriptional state of the host
in both infected and bystander cells (Figure 2). An initial example
of this came from the demonstration that persistent LCMV infec-
tion can cause runting of mice by altering growth hormone gene
expression without damaging the cells that secrete the hormone
(de la Torre and Oldstone, 1992; Valsamakis et al., 1987). A few
studies have directly assessed the effects of chronic herpesvirus
infection on expression of host genes in the liver, spleen, and
brain, revealing substantial effects that are both virus and organ
specific (Canny et al., 2014; White et al., 2012). Many of the
observed changes in gene expression overlap with interferon-
induced transcriptional programs, suggesting a role for virus-
induced cytokine expression. These studies are notable because
humans carry multiple chronic herpesvirus infections for life.
Proof that the virome alters transcription in uninfected cells
comes from studies of enteric norovirus infection, which alters
epithelial cell gene expression in uninfected cells in a manner
dependent on autophagy gene expression (Cadwell et al.,
2010). Furthermore, recent single-cell studies in rotavirus-in-
fected mice reveal changes in gene expression in both infectedcells and uninfectedbystander cells (Sen et al., 2012). Virus infec-
tion can trigger changes in bystander cells through inducing
release of interferons, other cytokines, or cGAMP(20-50) (Ablasser
et al., 2013;Cannyet al., 2014;Senet al., 2012;White et al., 2012).
It is likely that many such mechanisms remain undiscovered.
Although such transcriptional imprinting by the virome may
provide mutualistic benefit in some cases, there are untoward
effects as well. For example, chronic infection of mice with a
single herpesvirus can increase resistance to Listeria monocyto-
genes and Yersinia pestis (Barton et al., 2007), activate NK cells
and increase resistance to tumor grafts (White et al., 2010), delay
onset of type 1 diabetes in NOD mice (Smith et al., 2007), and
decrease adenoviral infection (Nguyen et al., 2008). However,
the same infection can increase susceptibility to autoantigen-
driven experimental allergic encephalomyelitis (Peacock et al.,
2003) and either increase or decrease malaria lethality depend-
ing on the kinetics of herpesvirus infection (Haque et al., 2004).
Therefore, the complexity of the effects of the virome’s role in
determining the transcriptional state of the asymptomatic host
is likely to be high, with cost versus benefit for the host balanced
on a knife’s edge.
Virotype Hypothesis
The concept that viruses within the virome regulate transcription
in asymptomatic hosts in variable ways depending on host ge-
netics presents a very complicated view of individual variation
and disease mechanisms. The underlying complexity of mecha-
nisms implicit in this conceptualization is daunting (although
perhaps correct) and at a minimum offends the sensibility that
there should be simple underlying rules that we can decipher
and leverage to our own benefit. How then can we reduce this
complexity to manageable and testable hypotheses? Under-
standing the role of the virome in health and disease will certainly
require annotating the structure of the virome itself, but this alone
does not present an obvious avenue to defining how the virome
relates to host biology.
In this regard, it is notable that there are many different host
molecules that sense the presence of viruses and elicit transcrip-
tional responses. These ever-better-understoodmolecules differ
in the nature of the virus types and virus-derived ligand(s) recog-
nized (Figure 2). Further, the transcriptional programs induced by
these different sensors overlap but are distinct and cell type spe-
cific. This allows consideration of what is in common between
transcriptional responses to different viruses. Groups of viruses
that share cell tropism and the capacity to activate a given
sensor or set of sensors, termed herein ‘‘virotypes,’’ might be
predicted to elicit a predictable host transcriptional response.
The concept of virotypes is similar to that of an ecological guild,
with the unification of different species into a virotype based on
host responses rather than into a guild by exploitation of shared
resources. A virotype eliciting a shared host response might
reasonably be considered as a potential cause of disease or
an alteration in immunophenotype. The presence of a virotype
might thereby set up the host to respond in either a positive or
negative fashion to environmental or infectious triggers of dis-
ease (Figure 2).
This concept differs from current methods for phylogenetic
grouping of viruses used to seek new pathogens because aCell 157, March 27, 2014 ª2014 Elsevier Inc. 147
virotype might include different kinds of viruses unified by their
capacity to induce a specific host response. If a virotype-elicited
host transcriptional response predisposed to disease, then
standard approaches to linking a single virus to the disease,
for example by PCR or serologic analysis, would be fruitless
(Figure 2). However, identifying the relationship between a viro-
type and a disease might reveal a causative role for components
of the virome. This is attractive because evidence that infection
triggers autoimmunity and inflammation has been collected for
many years, but it has been difficult to link individual viruses to
specific inflammatory diseases by classical methods. The use
of metagenomic sequencing to characterize the virome during
disease, and in healthy individuals, would be an important first
step for testing this hypothesis.
Coda
The virome is an enormous and fast-evolving component of our
metagenome whose effects are only now coming to light. Our
understanding of the nature of the virome itself is incomplete
and rapidly changing as deep-sequencing efforts progress.
Major questions for future analysis of the virome include the
quantitative and qualitative description of the virome itself,
the effects of the virome on organs and tissues outside of the
immune system, the nature of trans-kingdom (and inter-virome)
interactions involving the virome, identification of PAMPS and
antigens within the virome that stimulate innate and adaptive
immunity, whether there are virotypes that share effects on the
host, how age-at-acquisition influences the impact of the virome
on the host, and how we can leverage understanding of the
virome for our own benefit.
It is clear that we are in for quite a ride as the capacity to
detect and quantify the virome becomes more widespread
through decreasing sequencing costs, improved annotation of
virome databases, and discovery of additional viral types. The
potential importance of the virome indicates the need for a
major effort to sequence and annotate the viruses that inhabit
us. A Human Virome Project is therefore needed to define the
genotype/phenotype relationship. The challenges for such an
effort, including preservation and sequencing of RNA and
DNA viruses of all types and annotating highly divergent viral
genomes, can be met by effectively linking existing basic
virology expertise to rapidly evolving sequencing and bio-
informatic technologies.
The virome is only one component of our metagenome, and
one that must not be studied in isolation from other parts of
the microbiome and our own genetics. The early findings from
studies of the virome, and other aspects of themicrobiome, point
to the need for a new science of metagenetics, defined as the
integrative analysis of the impact of genes of the host in the
context of the genes within the microbiome including the virome.
To be effective, practitioners in this field must not be divided into
silos that separate scientists with expertise in components of, or
responses to, the metagenome. The virome is in us and on us
and is likely to be recognized through metagenetic analysis in
the future as a friend at times and, at other times, as amore com-
plex enemy than we supposed. Both camaraderie and enmity
are likely to emanate from the virome in currently unrecognized
and unsuspected ways.148 Cell 157, March 27, 2014 ª2014 Elsevier Inc.ACKNOWLEDGMENTS
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